Alphina Therapeutics Inc.

American biotechnology company at New Haven in Connecticut, founded on work in DNA repair and metabolic vulnerability of tumours and backed by venture investors. Develops antibody drug conjugates that carry a payload inhibiting the NAD salvage enzyme NAMPT, a mechanism different from the cytotoxic payloads in current conjugates, and works on preclinical candidates for solid tumours.